Literature DB >> 32989579

Adding a Preoperative Dose of LMWH may Decrease VTE Following Bariatric Surgery.

Ahmed Mohammed Abdelsalam1, Ahmed Mohammed Salah Eldeen ElAnsary2, Mohammed Abdallah Salman2, Sahar Abdelrahman Nassef2, Hala Mostafa Elfergany2, Hesham Ahmed Abou Aisha2.   

Abstract

BACKGROUND: Bariatric procedures are the most effective management for obesity. There is no standard venous thromboembolism (VTE) prophylaxis for both dosing and duration of anticoagulation following laparoscopic sleeve gastrectomy. Our purpose was to assess the optimum regimen for VTE prophylaxis in bariatric procedures and to reduce the incidence of perioperative bleeding. METHODS AND MATERIALS: This is a prospective randomized study which involved 100 morbidly obese patients, subdivided into two groups; group A received postoperative low molecular weight heparin (LMWH) prophylaxis alone starting from day 1 to day 15 in dose 1 mg/kg/day in a maximum dose 120 mg/day, and group B received both pre- and postoperative LMWH; at night of surgery 12 h preoperatively and postoperative starting from day 1 to day 15 with the same dose. All patients underwent mesenteric and bilateral lower limbs duplex 15 days postoperative using Philips iU machine and linear (L9-3), convex (C5-1) and sector (S5-1) probes.
RESULTS: Regarding postoperative VTE, we found statistically significant increase in postoperative VTE in patients of group A (four cases) without any case complicated with VTE in patients of group B (P value = 0.041). Regarding postoperative bleeding, we found statistically insignificant percent of cases complicated with postoperative bleeding in group B compared to group A (P value 0.315).
CONCLUSION: Preoperative as well as a postoperative prophylactic anticoagulant as LMWH is recommended to prevent perioperative VTE. There was an insignificant increase in postoperative bleeding in patients who received preoperative prophylactic anticoagulants.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32989579     DOI: 10.1007/s00268-020-05782-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  8 in total

1.  Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures.

Authors:  Maria S Altieri; Jie Yang; Donglei Yin; Konstantinos Spaniolas; Mark Talamini; Aurora Pryor
Journal:  Surg Endosc       Date:  2018-12-10       Impact factor: 4.584

Review 2.  Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.

Authors:  L Sjöström
Journal:  J Intern Med       Date:  2013-02-08       Impact factor: 8.989

3.  A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery.

Authors:  Eldo E Frezza; Mitchell S Wachtel
Journal:  Obesity (Silver Spring)       Date:  2006-11       Impact factor: 5.002

4.  Postoperative venous thromboembolism rates vary significantly after different types of major abdominal operations.

Authors:  Debraj Mukherjee; Anne O Lidor; Kathryn M Chu; Susan L Gearhart; Elliott R Haut; David C Chang
Journal:  J Gastrointest Surg       Date:  2008-07-31       Impact factor: 3.452

5.  Metabolic/bariatric surgery worldwide 2011.

Authors:  Henry Buchwald; Danette M Oien
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

6.  Pulmonary embolism and deep venous thrombosis following bariatric surgery.

Authors:  Paul D Stein; Fadi Matta
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

7.  Prevention of venous thromboembolism with enoxaparin in bariatirc surgery.

Authors:  Hee Doo Woo; Yong Jin Kim
Journal:  J Korean Surg Soc       Date:  2013-04-24

Review 8.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.